141/553US=6 / Quimioterapia
Airley R. Checkpoint protein kinases as novel targets - mammalian target of rapamycin (mTOR). In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 245-8. ISBN 978-0-470-09254-5.

CHECKPOINT; PROTEINAS QUINASES; MTOR; ALVO DA RAPAMICINA EM MAMIFEROS; ATIVACAO DE MTOR; ANTICANCERIGENOS ALVO MTOR


142/553US=6 / Quimioterapia
Airley R. Telomerase. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 249-54. ISBN 978-0-470-09254-5.

TELOMERASE


143/553US=6 / Quimioterapia
Airley R. Histone deacetylase: an epigenetic drug target. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 255-63. ISBN 978-0-470-09254-5.

INIBIDORES DE HDAC; HISTONA DEACETILASE; DROGA EPIGENETICA; HDAC; EMBALAGEM DE DNA


144/553US=6 / Quimioterapia
Airley R. Pharmaceutical problems in cancer chemotherapy. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 265-80. ISBN 978-0-470-09254-5.

PROBLEMAS FARMACEUTICOS EM QUIMIOTERAPIA; MANIFESTACAO DE TOXICIDADE; REGIME DE TOXICIDADE; RESISTENCIA A DROGAS; COMPLICACOES FARMACEUTICAS


145/553US=6 / Quimioterapia
Airley R. Oncology pharmacy at home and abroad. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 281-2. ISBN 978-0-470-09254-5.

ONCOLOGIA FARMACIA EM CASA E NO EXTERIOR


146/553US=6 / Quimioterapia
Airley R. Practice exam questions. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 283-98. ISBN 978-0-470-09254-5.

QUIMIOTERAPIA. QUESTOES PRATICAS


147/553US=24 / Imagem
Feynman RP. Science of atomism: a brief history. In: Vallabhajosula S. Molecular imaging: radiopharmaceuticals for PET and SPECT. New York: Springer-Verlag, 2009. p. 11-23. ISBN 978-3-540-76734-3.

CIENCIA DO ATOMISMO; ATOMISMO; ELEMENTOS QUIMICOS; ELETRICIDADE E MAGNETISMO; TERMODINAMICA; REALIDADE DE ATOMOS; ESTRUTURA ATOMICA; PARTICULAS ELEMENTARES


148/553US=8 / Laboratório
Elbert BL, Golub TR, Armstrong SA. Genomic approaches to the study of hematologic science. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 16-24. ISBN 978-0-443-06715-0.

GENOMA; ABORDAGENS GENOMICAS; CIENCIA HEMATOLOGICA; HEMATOLOGIA; ANALISE DA EXPRESSAO DO GENE; ANALISE DE EXPRESSAO DO MICRORNA; POLIMORFISMOS DE NUCLEOTIDEO UNICO; SEQUENCIAMENTO DIRETO DOS GENES CANDIDATOS; AQUISICAO DA AMOSTRA E PREPARACAO; BIOINFORMATICA; LEUCEMIA; LINFOMA; DOENCA FALCIFORME; TROMBOSE; FARMACOGENETICA


149/553US=33 / Dor/Paliativo
Davis MP, Pasternak GW. Opioid receptors and opioid pharmacodynamics. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 1-27. ISBN 978-0-19-923664-0.

RECEPTORES OPIOIDES; FARMACODINAMICA OPIOIDE; OPIACEOS; PEPTIDEOS OPIOIDES; FARMACOGENOMICA ANTAGONISTAS; ANALGESIA OPIOIDE; TOLERANCIA ANALGESICO; DEPENDENCIA DOS OPIACEOS; DIMERIZACAO DE RECEPTORES DE OPIOIDES


150/553US=33 / Dor/Paliativo
Jackson II KC, Davis MP, Quigley C. Opioid pharmacokinetics. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 29-38. ISBN 978-0-19-923664-0.

FARMACOCINETICA DOS OPIOIDES


151/553US=33 / Dor/Paliativo
Davis MP. Liver disease and exogenous opioid pharmacokinetics. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 39-67. ISBN 978-0-19-923664-0.

DOENCA HEPATICA; FARMACOCINETICA DOS OPIOIDES EXOGENOS


152/553US=33 / Dor/Paliativo
Hardy JR. Opioids in renal failure. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 69-79. ISBN 978-0-19-923664-0.

OPIOIDES NA INSUFICIENCIA RENAL; DIALISE; BUPRENORFINA


153/553US=33 / Dor/Paliativo
Hardy JR, Jackson II KC. Codeine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 81-7. ISBN 978-0-19-923664-0.

CODEINA; FARMACOCINETICA; FARMACODINAMICA


154/553US=33 / Dor/Paliativo
Davis MP. Hydrocodone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 89-98. ISBN 978-0-19-923664-0.

HIDROCODONA; FARMACODINAMICA; FARMACOCINETICA; VIAS DE ADMINISTRACAO; INTERACOES MEDICAMENTOSAS; TOXIDADE DROGAS


155/553US=33 / Dor/Paliativo
Glare P. Dextropropoxyphene. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 119-25. ISBN 978-0-19-923664-0.

DEXTROPROPOXIFENO; FARMACOLOGIA; FARMACODINAMICA; DOSAGEM EM POPULACOES ESPECIAIS; DOR ONCOLOGICA. BASEADA EM EVIDENCIAS


156/553US=33 / Dor/Paliativo
Glare P. Morphine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 127-53. ISBN 978-0-19-923664-0.

MORFINA; FARMACOLOGIA; FARMACODINAMICA; FARMACOCINETICA; FARMACOLOGIA DA MORFINA GLUCORONIDOS; INTERACOES DRUNG; TOXICIDADE; DOSAGEM EM POPULACOES ESPECIAIS; CANCER. BASEADA EM EVIDENCIAS


157/553US=33 / Dor/Paliativo
Glare P, Davis MP. Oxycodone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 155-73. ISBN 978-0-19-923664-0.

OXICODONA; FARMACODINAMICA; FARMACOCINETICA; OXICODONA PARA A DOR ONCOLOGICA


158/553US=33 / Dor/Paliativo
Hall A, Hardy JR. The lipophilic opioids: fentanyl, alfentanil, sufentanil, and remifentanil. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 175-92. ISBN 978-0-19-923664-0.

OPIOIDES LIPOFILICOS; FENTANIL; ALFENTANIL; SUFENTANIL; REMIFENTANIL; ADMINISTRACAO TRANSDERMICA; INFUSAO SUBCUTANEA; ADMINISTRACAO TRANSMUCOSA; ADMINISTRACAO INTRANASAL


159/553US=33 / Dor/Paliativo
Davis MP. Buprenorphine. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 193-209. ISBN 978-0-19-923664-0.

BUPRENORFINA; FARMACODINAMICA; FARMACOCINETICA; INTERACOES MEDICAMENTOSAS; TOXICIDADE; DOR DO CANCER. BASE DE EVIDENCIAS; ROTACAO DE OPIOIDES A BUPRENORFINA


160/553US=33 / Dor/Paliativo
Davis MP, Quigley C. Methadone. In: Davis MP, Glare P, Hardy JR, Quigley C, editors. Opioids in cancer pain: science, evaluation, and management, na interdisciplinary approach. 2nd ed. Oxford: Oxford Univeristy Press, 2009. p. 211-43. ISBN 978-0-19-923664-0.

METADONA; FARMACODINAMICA; FARMACOCINETICA; MONITORIZACAO TERAPEUTICA; TOXICIDADE; METADONA EM CANCER AVANCADO


Primeira | Anterior | Próxima | Última